Insight Molecular Diagnostics Inc. · NASDAQ:IMDX
Insight Molecular Diagnostics Inc. shareholders
As of Sep 30, 2026, 42 institutions reported holding Insight Molecular Diagnostics Inc., 56.6% of its shares. Largest: Broadwood Capital Inc, AWM Investment Company, Inc. and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Insight Molecular Diagnostics Inc. | Change | Filed |
|---|---|---|---|---|
| Broadwood Capital Inc | 12.7M | 38.7% | no change | Nov 13, 2026 |
| AWM Investment Company, Inc. | 2.77M | 8.5% | −64,927 | Nov 13, 2026 |
| Vanguard | 895K | 2.7% | +29,029 | Nov 13, 2026 |
| Family Office Research LLC | 650K | 2.0% | +281K | Oct 14, 2026 |
| Geode Capital | 271K | 0.83% | +13,655 | Nov 6, 2026 |
| FNY Investment Advisers, LLC | 242K | 0.74% | +59,703 | Oct 16, 2026 |
| Two Sigma | 202K | 0.62% | +191K | Nov 16, 2026 |
| BlackRock | 149K | 0.45% | −1,995 | Nov 13, 2026 |
| State Street | 122K | 0.37% | +29,500 | Nov 12, 2026 |
| Walleye Capital LLC | 57,587 | 0.18% | new | Nov 13, 2026 |